NCT04771637View on ClinicalTrials.gov

Effect of Dexmedetomidine on Perioperative Internal Environment and Rehabilitation of Patients Undergoing Gastrointestinal Malignant Tumor Resection

NACompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

August 30, 2020

Study Completion Date

August 30, 2020

Conditions
DexmedetomidinePerioperativeElectrolyte
Interventions
DRUG

Dexmedetomidine

The loading dose with 0.5 μg/kg, maintenance dose with 0.5 μg/kg of Dexmedetomidine is used to observe the effect on the electrolyte and quality of recovery of the patients

DRUG

Dexmedetomidine

The loading dose with 1.0 μg/kg, maintenance dose with 0.25 μg/kg of Dexmedetomidine is used to observe the effect on the electrophysiology and quality of recovery of the patient

DRUG

Dexmedetomidine

The loading dose with 1 μg/kg, maintenance dose with 0.5 μg/kg of Dexmedetomidine is used to observe the effect on the electrophysiology and quality of recovery of the patients

DRUG

Normal saline

Normal saline is used to observe the effect on the electrophysiology and quality of recovery of the patients

Trial Locations (1)

225012

the Affiliated Hospital of Yangzhou University, Yangzhou

All Listed Sponsors
lead

Yangzhou University

OTHER

NCT04771637 - Effect of Dexmedetomidine on Perioperative Internal Environment and Rehabilitation of Patients Undergoing Gastrointestinal Malignant Tumor Resection | Biotech Hunter | Biotech Hunter